RXLIST®

What Is Beqalzi? Beqalzi (sonrotoclax) is a BCL-2 inhibitor indicated for adults with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a Bruton's tyrosine kinase (BTK) inhibitor. What Are Side Effects of Beqalzi?

Description for Veppanu Vepdegestrant is a heterobifunctional protein degrader. It is a small molecule comprised of an estrogen receptor binding domain joined by a linker to an E3 ligase binding domain. The chemical name of vepdegestrant is 2,6-piperidinedione, 3-[1,3-dihydro-1-oxo-5-[4-[[1-[4-[(1R,2S)-1,2,3,4-tetrahydro-6-hydroxy-2-phenyl-1-naphthalenyl]phenyl]-4-piperidinyl]methyl]-1-piperazinyl]-2H-isoindol-2-yl]-, (3S)-.

Generic Name: d Brand Name: d Last updated on RxList: 5/11/2026

What Is Otarmeni? Otarmeni (lunsotogene parvec-cwha) is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss (any frequency greater than 90 dB HL) associated with molecularly confirmed biallelic variants in the OTOF gene, preserved outer hair cell function, and no prior cochlear implant in the same ear. What Are Side Effects of Otarmeni?

Description for Idvynso IDVYNSO is a fixed-dose combination tablet for oral administration containing doravirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI), and islatravir, an HIV-1 nucleoside analog reverse transcriptase inhibitor (NRTI). Each film-coated tablet contains 100 mg of doravirine and 0.25 mg islatravir as active ingredients.

Medical Reviewer: John P. Cunha, DO, FACOEP Last updated on RxList: 4/10/2026 What Is Lifyorli? Lifyorli (relacorilant) is a selective glucocorticoid receptor antagonist indicated in combination with nabpaclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received 1-3 prior systemic treatment regimens, at least one of which included bevacizumab. What Are Side Effects of Lifyorli?

Lynavoy is used to treat itching in adults with primary biliary cholangitis (PBC). It works by blocking a protein in your gut called the ileal bile acid transporter (IBAT). This reduces the amount of bile acids your body takes back in, which causes them to be removed through your stool. This process helps lower the levels of substances in your blood that cause itching. Lynavoy is available under the following different brand names: Lynavoy.

Medical Reviewer: John P. Cunha, DO, FACOEP Last updated on RxList: 4/9/2026 What Is Lynavoy? Lynavoy (linerixibat) is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. What Are Side Effects of Lynavoy?

WARNING RISK OF THYROID C-CELL TUMORS In products with glucagon-like peptide-1 (GLP-1) receptor agonist activity that are pharmacologically active in rats and mice, rodent thyroid C-cell tumors (adenomas and carcinomas) have been observed at clinically relevant exposures and are considered GLP-1 receptor-dependent effects in rodents. Orforglipron is not pharmacologically active in rats or mice and did not produce tumors in rodents.

What Is Icotyde? Icotyde (icotrokinra) is an interleukin-23 (IL-23) receptor antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy. What Are Side Effects of Icotyde? Side effects of Icotyde include: headache, nausea, cough, fungal infection, and fatigue.